Breast Neoplasms
Showing 26 - 50 of >10,000
Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of
Not yet recruiting
- Organoids
- +2 more
- Biopsy
- (no location specified)
Nov 24, 2023
Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Antivascular therapy
- Chemotherapy
- (no location specified)
Jun 11, 2023
Breast Cancer, Breast Tumors, Surgery Trial in Jette, Genk (Patient-centered teleprehabilitation)
Recruiting
- Breast Cancer
- +2 more
- Patient-centered teleprehabilitation
-
Jette, Brussels, Belgium
- +1 more
Mar 22, 2023
Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole
Recruiting
- Triple Negative Breast Cancer
- +3 more
- Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 15, 2023
Breast Tumors Trial in Padova (Personalized screening protocol)
Active, not recruiting
- Breast Neoplasms
- Personalized screening protocol
-
Padova, ItalyIstituto Oncologico Veneto (IRCCS)
Dec 21, 2022
Young Patients With Early Breast Cancer
Not yet recruiting
- Breast Cancer Female
- operation
- (no location specified)
Sep 6, 2023
TNBC - Triple-Negative Breast Cancer Trial in Nanjing (Fluzoparib+Paclitaxel, Epirubicin+Cyclophosphamide)
Recruiting
- TNBC - Triple-Negative Breast Cancer
-
Nanjing, Jiangsu, ChinaJiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Apr 27, 2023
Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer Trial in Boston (MRI)
Recruiting
- Breast Cancer
- +5 more
- MRI
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 9, 2022
Megakaryocytes and Platelets in Breast Cancer
Not yet recruiting
- Breast Cancer
- Blood draw
- (no location specified)
Aug 21, 2023
Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)
Not yet recruiting
- Breast Neoplasms
- Trilaciclib
- +7 more
-
Guangzhou, Gangdong, ChinaSun-yat sen university cancer center
Jul 30, 2023
Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)
Recruiting
- Breast Cancer Stage IV
- Datopotamab deruxtecan
-
Vienna, AustriaAKH Universitaetsklinikum Vienna, Department f. Internal medicin
May 19, 2023
Breast Tumors, Breast Cancer, Left Sided Breast Cancer Trial in Taipei (PERSBRA)
Enrolling by invitation
- Breast Neoplasms
- +2 more
- PERSBRA
-
Taipei, TaiwanTaipei Medical University Hospital
Nov 3, 2022
Breast Tumors, Breast Tumor Female, Cancer, Breast Trial in Montréal (Thoracic paravertebral block multiple (3) injections,
Recruiting
- Breast Neoplasms
- +3 more
- Thoracic paravertebral block multiple (3) injections
- Thoracic paravertebral block single injection
-
Montréal, Quebec, CanadaCIUSSS de l'Est de l'Île de Montréal
Feb 3, 2023
Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)
Not yet recruiting
- Triple-negative Breast Cancer
- Pembrolizumab 25 mg/ml
- Paclitaxel injection
- (no location specified)
Oct 11, 2023
Breast Tumors, Breast Cancer Trial (PACHA Program)
Not yet recruiting
- Breast Neoplasms
- Breast Cancer
- PACHA Program
- (no location specified)
Jun 6, 2023
Breast Cancer, Breast Tumors, Breast Carcinoma Trial in Boston (Breast Cancer Survivor Education Program)
Not yet recruiting
- Breast Cancer
- +3 more
- Breast Cancer Survivor Education Program
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 17, 2023
Improvement of Vaginal Health in Breast Cancer, ARISE Study
Recruiting
- Breast Neoplasms
- Biospecimen Collection
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 13, 2023
Breast Cancer Stage I Trial (Microwave ablation)
Not yet recruiting
- Breast Cancer Stage I
- Microwave ablation
- (no location specified)
May 23, 2023
Early Breast Lesions
Not yet recruiting
- Breast Cancer
- Nanomechanical Phenotype Test
-
Houston, TexasBaylor College of Medicine
Oct 10, 2023
Patients Who Had Breast Cancer With Dense Breast Tissue
Not yet recruiting
- Breast Cancer
- Questionnaire/Interview
-
Houston, TexasMD Anderson Cancer Center
Nov 7, 2023
Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant
Not yet recruiting
- Breast Cancer Triple Negative
- +3 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
May 18, 2023
Breast Cancer Female Trial (State-Trait Anxiety Inventory (STAI))
Not yet recruiting
- Breast Cancer Female
- State-Trait Anxiety Inventory (STAI)
- (no location specified)
Aug 18, 2023
Breast Cancer Trial in Ansan (MRI)
Completed
- Breast Cancer
- MRI
-
Ansan, Korea, Republic ofBo Kyoung Seo
Oct 18, 2023
Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Imatinib 400 MG Oral Tablet
-
Gothenburg, SwedenBarbro Linderholm
Feb 1, 2023
Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)
Not yet recruiting
- Triple Negative Breast Cancer
- Doxorubicin
- +3 more
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
May 24, 2023